Navigation Links
Governor Rendell Proclaims Sept. 9-15 as 'Senior Community Center Week'
Date:9/7/2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... a bigger thrill when on an emotional rollercoaste...althDay News) -- Call it the fear factor meets the...at spectators -- especially those who root for the...f it,s a closely contested match and victory was i...air. , Chew on that this Thanksgiving weekend a...
(Date:11/26/2009)... Benton Communications announces ...wth system for retailers struggling to make an eco... November 26, 2009 -- Flu fears is the type of cha... emergency room, according to Dr. David Benton, bu...sed business growth system – The Rfactor In...
(Date:11/25/2009)...EMERYVILLE,Calif.,Nov.25/PRNewswire-FirstCall/-- ...cedthatthecompanywillhosttwoinvestoreventsinDecemb...:00a.m.CT/10:00a.m.ET ,, Principalinvestigato...ibinrelapsedand/orrefractorymultiplemyeloma,asfeat...lMeetingandExpositioninNewOrleans,LA.Theteleconfer...
(Date:11/25/2009)...SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--An...erforDrugEvaluationandResearch,titled"ADifficultBa...intheNov.26,2009issueofTheNewEnglandJournalofMedic...rnh/20090824/FDALOGO ) ,, Inthearticle,Woodcock...painmedicationforthosewhoneeditandmanagingtherisks...
(Date:11/25/2009)...erm survivors of testicular cancer who were treate...e side effects, including neurological side effect...t treated with chemotherapy, according to a new st...f the National Cancer Institute . , Marianne Bry... University Hospital, in Bergen, Norway, and colle...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...L. Myers, President, Campaign for Tobacco-Free Ki...ment of Matthew L. Myers, President, Campaign for ...r Latin America and the world, both the,Mexico Cit...Federal District Legislative Assembly (ALDF) appro...
...esearchers at Mayo Clinic and the Virginia Bioinfo...nt from the National Institute of Allergy and Infe...f the role of environmental fungi in chronic airwa...ntal fungus Alternaria triggers airway inflammatio...
... Feb. 27 Versus,Technology, Inc. ("Versus" or the...ts first fiscal quarter ended January 31, 2008, a ...ame quarter of the prior,year. Versus, quarterly r... are not necessarily indicative of what full,year ...
...us Americans Driving Dental Implant and Facial ...search Group, WALTHAM, Mass., Feb. 27 According ...re Volumes 2008 report, dental implants,and facial...h are only growing at CAGRs of under 5%. Aesthetic...
...ference Call on Tuesday, March 4th at 2:00 pm ET -.... (Amex: HH ) today announced that it will host a...uesday, March 4th at 2:00 pm ET. The,Company,s new...recent leadership,transition and near-term operati...
..., Feb. 27 John Miller, Chief,Executive Officer of...recent appointment of Nancy Frost as the Vice Pres...CA-based insurance intermediary and broker., Addr...ployee Benefits arena. She has spent over twenty y...
Other Medicine News:Health News:Mexico City's New Smoke-Free Law Sets Example for Latin America and World 2Health News:Mexico City's New Smoke-Free Law Sets Example for Latin America and World 3Health News:VBI, Mayo Clinic investigate link between fungal proteins, innate immunity and asthma 2Health News:VBI, Mayo Clinic investigate link between fungal proteins, innate immunity and asthma 3Health News:Versus Technology Announces First Quarter Results 2Health News:Versus Technology Announces First Quarter Results 3Health News:Versus Technology Announces First Quarter Results 4Health News:Versus Technology Announces First Quarter Results 5Health News:Versus Technology Announces First Quarter Results 6Health News:Cosmetic Procedures Outpace All Other Surgical Procedures 2Health News:Hooper Holmes to Provide Business Update 2Health News:Nancy Frost Joins Lawson-Hawks as Employee Benefits Vice President 2
(Date:11/25/2009)...25/PRNewswire/--TheFDAgrantedtraditionalapprovalfo...ereversetranscriptaseinhibitor(NNRTI).INTELENCEist...experiencedadultswhoareexperiencingvirologicfailur...roviral(ARV)agents.Thetraditionalapprovalisbasedon...T-2.INTELENCEiscurrentlymarketedintheU.S.byTibotec...
(Date:11/25/2009)....25/PRNewswire/--RegadoBiosciences,aprivatelyheldc...swithactivecontrolagents,announcedthatDavidMazzo,P...ay21stAnnualHealthCareConferenceattheNewYorkPalace...enat1:10pm(EST)onTuesday,December1andwillincludean...ddevelopmentprogram,theanticoagulantsystem,REG1.Th...
(Date:11/25/2009)...25/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX...rebloodanalysissystems,announcedtodaythatClintSeve...tthe21stAnnualPiperJaffrayHealthCareConferenceonWe...llbeheldattheNewYorkPalaceHotelinNewYorkCity. ,...ndmarketsportablebloodanalysissystemsforuseinanyve...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation 5646 1HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation 5646 2Lilly Surpasses Energy Efficiency Goals and Celebrates Worldwide Energy Day 5643 1Lilly Surpasses Energy Efficiency Goals and Celebrates Worldwide Energy Day 5643 2NGM Biopharmaceuticals Appoints Dr Arthur D Levinson Former Genentech CEO to its Board of Directors 5640 1NGM Biopharmaceuticals Appoints Dr Arthur D Levinson Former Genentech CEO to its Board of Directors 5640 2NGM Biopharmaceuticals Appoints Dr Arthur D Levinson Former Genentech CEO to its Board of Directors 5640 3
...ical data for potential combination,therapies and ...r,ITMN-191 exposure, BARCELONA, Spain, April 11, 2...unced today the presentation of findings from,thre... inhibitor,ITMN-191, alone or in combination with ... European Association for the Study of the,Liver i...
...IRE)--Apr 11, 2007 - New data,supporting the clini... most advanced investigational oral protease inhib... infection, will be presented,at the 42nd Annual M...f the Liver (EASL) in Barcelona this week. In tota...accepted for presentation,at the EASL conference, ...
Other Medicine Technology:InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 2Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 5Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 6
1.0 mm Micro System
Grafton DBM Matrix PLF
Optium DBM Gel, TGEL05
...w generation Endoalpha is a centralized O.R. contr...urse by giving them better control, better informa...protection against obsolescence, as future enhance... than the purchase of an entirely new system. Endo...
Medicine Products: